Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
US8383612B2 · kind B2 · utility
0Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 1, 2005 |
| Grant date | Feb 26, 2013 |
| Priority date | — |
| Expiry date | Nov 24, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace®; MA) in patients with heart insufficiency and after a myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.